Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.
| Metric | SURGY | NXDT | OLP | GOOD | CTO | JBGS | Ind. Median |
|---|---|---|---|---|---|---|---|
| P/E | 628.01 | — | 22.91● | 28.43 | 82.95 | — | 13.27 |
| P/B | 1.22 | 0.39● | 1.80 | 3.67 | 1.21 | 0.79 | 0.75 |
| EV/EBITDA | 45.35 | — | 14.38 | 22.45 | 9.78● | 18.26 | 14.38 |
| P/S | — | 8.33 | 5.59 | 3.62 | 4.50 | 1.79● | 6.34 |
| Metric | SURGY | NXDT | OLP | GOOD | CTO | JBGS | Ind. Median |
|---|---|---|---|---|---|---|---|
| Current Ratio | 19.26● | 0.07 | 1.43 | 0.39 | 7.23 | 1.11 | 1.95 |
| Debt/Equity | 0.0%● | 39.6% | 194.2% | 515.7% | 112.9% | 225.5% | 22.5% |
| NetDebt/EBITDA | -0.14 | -2.98● | 7.33 | 13.06 | 4.51 | 13.35 | 0.88 |
| Metric | SURGY | KGYO | DGGYO | AHSGY | VKGYO | SRVGY | Ind. Median |
|---|---|---|---|---|---|---|---|
| P/E | 628.01 | — | — | 5.08 | 11.72 | 3.60● | 13.27 |
| P/B | 1.22 | 8.66 | 0.83 | 1.56 | 0.35 | 0.22● | 0.75 |
| EV/EBITDA | 45.35 | — | 16.62 | 4.68 | 2.99 | 1.42● | 14.38 |
| P/S | — | 5.95 | 10.14 | 29.35 | 3.57 | 2.13● | 6.34 |
| Metric | SURGY | KGYO | DGGYO | AHSGY | VKGYO | SRVGY | Ind. Median |
|---|---|---|---|---|---|---|---|
| Current Ratio | 19.26 | 0.73 | 0.10 | 38.06● | 3.88 | 4.07 | 1.95 |
| Debt/Equity | 0.0%● | 55.3% | 25.6% | 0.0% | 0.0%● | 1.9% | 22.5% |
| NetDebt/EBITDA | -0.14 | -0.76 | 3.87 | -0.37 | -1.03● | -0.01 | 0.88 |
The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.
Data on this page refreshes once per day. Price data as of Jul 3, 26. This content is for informational purposes only and is not investment advice.